… A retrospective observational study of nonvalvular atrial fibrillation patients initiating apixaban,
dabigatran, rivaroxaban, or warfarin from January 1, 2013, to September 30, 2015, was …

… Therefore, the objective of the current study was to assess the safety, effectiveness, and
continued use (ie medication persistence) of rivaroxaban and warfarin in patients with …

… power necessary to evaluate both effectiveness and safety. Sixth, this study only … patients
because a comparison between patients who switched from warfarin to apixaban and patients …

Background and Objective Atrial fibrillation (AF), the most common cardiac arrhythmia,
typically increases with age. Oral anticoagulants (OACs) are the cornerstone of treatment to …

Catheter ablation is a promising therapy for atrial fibrillation (AF), but its utility in patients with
left ventricular systolic dysfunction (LVSD) is uncertain. The objectives of this study were to …

Background and Purpose: Several observational studies have compared the effect of the
non–vitamin K antagonist oral anticoagulants to each other in patients with atrial fibrillation. …

… for this group of patients. While two ad hoc analyses of patients with polypharmacy have …
-world evidence about the safety and effectiveness of OACs among patients with polypharmacy. …

… As stated above, selection bias will account for this, because patients at … effectiveness and
safety findings add to the existing literature. Although the Danish nationwide atrial fibrillation …

… patient-years). Rivaroxaban treatment discontinuation occurred in a total of 277 patients during
follow-up (12.0/100 patient… confirmation of effectiveness and relative safety of rivaroxaban …

… reviewed and meta-analyzed observational studies assessing the comparative
effectiveness and safety of DOACs for stroke prevention in patients with atrial fibrillation (AF). …